Starling Oncology, Inc.
STLN- Exchange
- Nasdaq
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001799191
In the last 90 days, Starling Oncology, Inc. insiders filed 3 open-market purchases and 2 sales; 119 institutions reported holding it in 13F filings for Q2 2026, worth $217.6M in total; no superinvestor holds it.
Q4 2024 vs. Q3 2024
How the institutions holding Starling Oncology, Inc. changed between Q3 2024 and Q4 2024.
All holders in Q4 2024All holders in Q3 2024
| Measure | Q3 2024 | Q4 2024 | Change |
|---|---|---|---|
| Holders | 34 | 31 | −3 |
| Shares | 20.6M | 14.7M | −5.88M (−28.5%) |
| Value | $6.73M | $4.61M | −$2.12M (−31.5%) |
New holders (5)
Institutions that held Starling Oncology, Inc. at the end of Q4 2024 but not at the end of Q3 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 131,759 | $41.0K | 0.00% |
| UBS Group AG | 61,961 | $19.1K | 0.00% |
| Scientech Research LLC | 21,198 | $6.55K | 0.00% |
| BNP Paribas Arbitrage, SA | 5 | $2 | 0.00% |
| Capital Advisors, Ltd. LLC | 1,219 | $0 | 0.00% |
Sold out (8)
Institutions that held Starling Oncology, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.
| Institution | Shares, Q3 2024 | Value, Q3 2024 |
|---|---|---|
| FMR LLC | 4,749,900 | $1.55M |
| Kent Lake PR LLC | 2,000,000 | $653.8K |
| Citadel Advisors LLC | 91,337 | $29.9K |
| Susquehanna International Group, LLP | 34,411 | $11.2K |
| Cresset Asset Management, LLC | 18,300 | $5.98K |
| Two Sigma Securities, LLC | 16,997 | $5.56K |
| Qube Research & Technologies Ltd | 15,642 | $5.11K |
| Boston Financial Mangement LLC | 2,679 | – |